16 Results Found

MSD Merck Sharp & Dohme Opens Global Innovation and Development Hub to ‘The Circle’ in Zurich

Go to all press releases Zurich, December 9, 2021 – MSD Merck Sharp & Dohme AG known as Merck & Co, Inc, Kenilworth, N.J., USA in the United States and Canada (NYSE: MRK) – has opened the doors to its new Innovation and Development Hub in Zurich. The new MSD Zurich Hub at “The Circle” […]

Dr Corinna Lenz appointed new site manager at the MSD Merck Sharp & Dohme AG biopharmaceutical development and forensics unit in Schachen, Lucerne

MSD Merck Sharp & Dohme AG has appointed Dr Corinna Lenz as the new site manager of the Swiss research and development unit at Werthenstein BioPharma GmbH. Corinna Lenz is replacing Justin Pennington who occupied the role in a temporary capacity. Werthenstein BioPharma GmbH plays a key role in the global provision of new innovative […]

MSD (Merck Sharp & Dohme) announced the spin-off of its women’s health, established brands and biosimilars businesses into a new independent company with sustainable growth: Organon & Co will be based in Lucerne.

MSD Merck Sharp & Dohme announced on February 5, 2020, the spinoff of its women’s health, proven established brands and biosimilars businesses to a new independent company. The transaction is expected to be completed during Q2 of 2021. Organon & Co (Organon), the name of the new spin-off, has a strong brand value and is […]

11-16  of  16